Day: September 11, 2023
Anticipate completion of Phase 1 & Phase 2 clinical trials in chronic pruritis over the next approximately 12 months
Seeking first approval in an orphan disease, PBC, for the treatment of moderate to severe chronic pruritis in which more than 70% of patients suffer from chronic pruritis
BRIDGEWATER, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”), a biotechnology company developing therapeutic candidates targeting drug resistant and devastating cancer announces an exclusive option agreement to acquire a clinical stage asset, AV104, with a recently approved IND. AV104 has a dual mechanism of action by affecting multiple receptors, known to suppress chronic, debilitating pruritis or “uncontrollable itching”. The Company intends to first...
Bon Natural Life Limited Announces Record First Half-Year Revenue and Net Income
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Magenta Therapeutics Announces Completion of Merger with Dianthus Therapeutics and Implementation of Reverse Stock Split
Written by Customer Service on . Posted in Mergers And Acquisitions.
The combined company will operate as “Dianthus Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “DNTH” effective Tuesday, September 12, 2023
CAMBRIDGE, Mass., Sept. 11, 2023 (GLOBE NEWSWIRE) — Magenta Therapeutics, Inc. (Nasdaq: MGTA) (“Magenta”) today announced completion of the merger with Dianthus Therapeutics, Inc. (“Dianthus”) following Magenta’s successful receipt of stockholder approval for all proposals related to the merger at a special meeting of stockholders. Magenta effected a reverse stock split of Magenta’s common stock immediately prior to the merger. Magenta following the merger is referred to herein as the “combined company.”
Steve Mahoney, President and Chief Financial and Operating Officer of Magenta said, “We are pleased with the outcome of the special meeting and appreciate our...
Forward Solutions Announces the Merger of George W. Mouk & Associates into Avision
Written by Customer Service on . Posted in Mergers And Acquisitions.
HERSHEY, Pa., Sept. 11, 2023 (GLOBE NEWSWIRE) — Forward Solutions, a leading provider of outsources sales and marketing, is excited to announce the successful merger of George W. Mouk & Associates and Avision. This strategic collaboration marks a significant step towards enhancing service offerings and increasing market presence.
George W. Mouk & Associates has been a leader in the foodservice and janitorial channel, serving customers in Louisiana, Mississippi, Arkansas, West Tennessee, Southern Alabama, and the Florida panhandle since 1970.
Lee Mouk, President of George W. Mouk & Associates, shared his anticipation about this merger, stating, “I look forward to being part of a team of professional sales reps and the increased ability to serve our manufacturer and distributor partners.” This strategic...
Mullen Acquires Battery Pack Production Assets From Romeo Power
Written by Customer Service on . Posted in Mergers And Acquisitions.
Assets purchased for approximately $3.5M includes equipment, inventory and IP for high volume EV battery pack production
BREA, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, today announces the purchase of battery pack production assets from Romeo Power for approximately $3.5 million. The deal includes equipment, inventory and intellectual property for high volume EV (electric vehicle) battery pack and module production.
The Romeo Power assets include production lines for EV pack assembly and precision R&D module and pack development with associated inventory allowing for production of modules and vehicle battery packs. Additionally the purchased assets include battery testing and validation equipment,...
Global Lyme Disease Treatment Market Size to Reach USD 1,826.3 Million in 2032 | Emergen Research
Written by Customer Service on . Posted in Mergers And Acquisitions.
Increase in the number of Lyme disease cases across the globe is a key factor driving market revenue growth
Vancouver, Sept. 11, 2023 (GLOBE NEWSWIRE) — The global Lyme disease treatment market size was USD Million 850.0 in 2022 and is expected to register a revenue CAGR of 8.5% during the forecast period, according to latest analysis by Emergen Research. Increasing investment by major companies and rising development in healthcare facilities and diagnostic procedures across the globe are projected to support revenue growth of the Lyme disease treatment market during the forecast period. For both people and animals suspected of having been in touch with the disease, the greater accuracy of Spectroscopic testing may improve diagnosis procedures for Lyme disease.
The new test could benefit mobile veterinary services for animals...
Global Bot Services Market Size to Reach USD 16.43 Billion in 2030 | Emergen Research
Written by Customer Service on . Posted in Mergers And Acquisitions.
National Fuel Releases its 2022 Corporate Responsibility Report Highlighting Safe, Reliable, Affordable and Sustainable Operations
Written by Customer Service on . Posted in Public Companies.